Background characteristics of young adults and non-young adults. by Yuichiro Ohya (13040293)

Subjects:

Stroke subtype of young adults and non-young adults. by Yuichiro Ohya (13040293)

Subjects:

Lower insular perfusion in the DAT group compared with the non-DAT group. by Masashi Takeuchi (1930312)

Toca-1 recruitment around wild-type bacteria is associated with decreased recruitment of LC3 and autophagy markers. by Leigh A. Baxt (550378)

Shifting <i>V. cholerae</i> from glucose-based to starch-based conditions leads to a decrease in CT production. by Juliane Kühn (669504)

Statins differentially alter NSPC fate through a non-CBP dependent mechanism. by Ross A. Carson (5184512)

Average awakening citation-intensity <i>c</i>_<i>a</i> for SN-SNPRs and SB-nonSNPRs with <i>s</i> = 5. by Anthony F. J. van Raan (7517696)

Intravitreal ALF-186 decreased the IRI-induced capsase-3 and NF-κB mRNA expression and affected the heat-shock response differently. by Julia Stifter (4621033)

Functional consequences of absence of glycosylation in class II strains. by Joseph Gault (427444)

Effect of lysosomal hydrolysis inhibition on the decrease of PrP^Sc levels induced by CPZ or U18666A treatment. by Takeshi Yamasaki (521196)

A315T TDP-43 mice develop marked obesity with a concomitant increase in adipose and decrease in lean mass percentage. by Nancy R. Stallings (444999)

50 WT 5′ and 3′ terminal nts of the S1 gene are sufficient to package a non-MRV gene into infectious virions. by Debarpan Dhar (724473)

Human preterm infants diagnosed with IUGR have decreased Paneth cell counts compared to preterm non-IUGR control infants. by Camille M. Fung (844334)

“…(A) IUGR infants had similar numbers of goblet cells per 100 epithelial cells compared to non-IUGR infants (p = 0.5). …”

Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc by Lei Wang (6656)

“…Background<p>Pralsetinib is a selective RET inhibitor. The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”

Image_5_miR-144-5p and miR-451a Inhibit the Growth of Cholangiocarcinoma Cells Through Decreasing the Expression of ST8SIA4.tif by Wan Fu (3681799)

“…This study aimed to investigate the action mechanism of miR-144-5p and miR-451a in cholangiocarcinoma. We found that miR-144-5p and miR-451a were significantly decreased in cholangiocarcinoma patient samples compared to the adjacent normal bile duct samples. …”

In vivo targeting of miR-155-5p with an antagomir effectively decreases expression but has no impact on disease. by Maximilian W. Plank (839968)

Decrease in accelerometer assessed physical activity during the first-year post-myocardial infarction: a prospective cohort study by Amanda Lönn (11583010)

Lower insular perfusion in patients with hypoactive delirium compared with the non-DAT group. by Masashi Takeuchi (1930312)

Decreased Muscle Strength of Knee Flexors Is Associated With Impaired Muscle Insulin Sensitivity in Non-Diabetic Middle-Aged Japanese Male Subjects by Yuki Someya (770709)

Inhibition of SKI-1/S1P enzymatic activity using PF-429242 impairs activation of the SREBP pathway and correlates with a dramatic decrease in lipid droplet number and area. by Anastasia Hyrina (3860455)